ORALMEDIC PRO™ is only sold outside the United States. This product is not yet cleared for distribution in the United States by the FDA. It is available to healthcare professionals, pharmacies and consumers in many countries. ORALMEDIC® is also branded in Europe and Canada as ORALMEDIC PRO™ Oral Ulcer Treatment.

ORALMEDIC PRO™ is the latest topical oral care product that is designed to be used by healthcare professionals. The product is intended to be used to relieve the local pain and discomfort caused by superficial disease or minor injury to oral tissues. ORALMEDIC PRO™ acts through a chemical process that produces superficial tissue denaturization following a brief direct topical application to the site of the lesion. Superficial tissue cleaning and coagulation leaves behind a thin barrier of precipitated organic material that protects the ulcer from further painful stimulation by materials in the oral cavity during the natural healing process.

ORALMEDIC PRO™ is most commonly used to treat oral ulcers, commonly also referred to as canker sores, apthae, or aphthous ulcers. The product's unique chemical and physical properties are particularly useful whenever a medical clinician needs a controlled local treatment for ulcers or minor abrasions.

ORALMEDIC PRO™ is the only treatment for Aphthous Stomatitis that completely stops oral ulcer pain, seals damaged oral mucosal tissues and aids natural healing processes after just one application.

See Application Instructions for use.